A breakthrough HIV prevention injection, lenacapavir, could be mass-produced at a fraction of its current list price, according to recent…
Browsing: Lenacapavir
Lenacapavir, a long-acting injectable HIV medication, may soon be a promising option for those starting HIV treatment. The latest findings…
Doctors Without Borders (MSF) has expressed support for a newly announced agreement aimed at expanding access to a more affordable…
The cost of the injectable HIV prevention medicine Lenacapavir will drop significantly, from $28,000 to just $40 per person per…
Kenya plans to introduce Lenacapavir, a long‑acting injectable for HIV prevention, beginning in January 2026 a step expected to strengthen…
In a groundbreaking development for HIV prevention, a new drug called Yeztugo has been approved as the first-ever twice-yearly injection…
A recent clinical trial has demonstrated success in preventing HIV in adolescent girls and young women. Conducted in Sub-Saharan Africa,…
An annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully completed an important early safety trial. The…
In a significant development for global HIV prevention, the World Health Organization (WHO) has welcomed the latest findings from the…